Search research articles
Contact Us
Filters
Showing results (171-180 of 418) with videos related to
Page
of 42
Sort By:
Journal of Nephrology
|
November 1, 2025
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy
James Larkin, Gaetano Alfano, Giulia Ligabue, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
John Haanen, Marc Ernstoff, Yinghong Wang, et al.
American Journal of Clinical Oncology
|
January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomes
James Larkin, Mayer Fishman, Laura Wood, et al.
Expert Opinion on Pharmacotherapy
|
December 22, 2012
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis
James Larkin, Abby Paine, Indra Tumur, et al.
Cancer Chemotherapy and Pharmacology
|
November 6, 2013
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
Ana M Molina, Thomas E Hutson, James Larkin, et al.
Cancer Cell
|
April 16, 2015
Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling
Eishu Hirata, Maria Romina Girotti, Amaya Viros, et al.
Frontiers in Immunology
|
April 10, 2024
Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes
Rene van Tienhoven, Diahann T S L Jansen, Miso Park, et al.
European Urology
|
April 4, 2026
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma
Sara Coca Membribes, Wenxin Xu, Cristina Suárez, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
The International Journal of Artificial Organs
|
February 9, 2026
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach
James Larkin, Giulia Ligabue, Gaetano Alfano, et al.
Page
of 42
Search research articles
Search
Showing results (171-180 of 418) with videos related to
Sort By:
Page
of 42
Journal of Nephrology
|
November 1, 2025
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy
James Larkin, Gaetano Alfano, Giulia Ligabue, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
John Haanen, Marc Ernstoff, Yinghong Wang, et al.
American Journal of Clinical Oncology
|
January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomes
James Larkin, Mayer Fishman, Laura Wood, et al.
Expert Opinion on Pharmacotherapy
|
December 22, 2012
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis
James Larkin, Abby Paine, Indra Tumur, et al.
Cancer Chemotherapy and Pharmacology
|
November 6, 2013
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
Ana M Molina, Thomas E Hutson, James Larkin, et al.
Cancer Cell
|
April 16, 2015
Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling
Eishu Hirata, Maria Romina Girotti, Amaya Viros, et al.
Frontiers in Immunology
|
April 10, 2024
Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes
Rene van Tienhoven, Diahann T S L Jansen, Miso Park, et al.
European Urology
|
April 4, 2026
KIM-1 in Advanced Papillary and Clear Cell Renal Cell Carcinoma
Sara Coca Membribes, Wenxin Xu, Cristina Suárez, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
The International Journal of Artificial Organs
|
February 9, 2026
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach
James Larkin, Giulia Ligabue, Gaetano Alfano, et al.
Page
of 42